The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in Japan
Abstract
Summary: A multi‐institutional collaborative study was conducted concerning the course of pregnancy and delivery and the incidence of abnormal infants delivered of epileptic women. Of 657 women receiving antiepileptic drugs, 73% delivered live infants, 14% had miscarriage or stillbirth, and 13% underwent induced abortion. In contrast to the above findings, 80% of 162 patients not receiving antiepileptic drugs delivered live infants and 4% had miscarriage or stillbirth. The latter outcome was significantly increased in the medicated patients. In this series, 63 (9.9%) of 638 live births were malformed, 55 (11.5%) being from medicated mothers and 3 (2.3%) from nonmedicated mothers. The incidence of fetal malformation in medicated mothers was thus five times as high as that in nonmedicated mothers. Cleft lip and/or palate and malformations involving the cardiovascular system were found frequently in the infants from medicated mothers. General background factors that might exert teratogenic effects on pregnant patients with epilepsy were studied, and the potential toxicity of antiepileptic drugs to the fetus was also analyzed. In this regard, consideration should be given to whether the patient has partial epileptic seizures, whether the patient herself exhibits any malformation, or whether her previous pregnancy resulted in an abnormal outcome. The incidence of fetal malformation was the highest (12.7%) in the medicated patients who had epileptic seizures during the pregnancy. It is presumed on the basis of the results of analysis of the data that a combination of more than three drugs and a daily dose greater than a certain minimal level is likely to produce malformed infants. ZUSAMMENFASSUNG: In vielen Institutionen wurde eine kollaborative Studie uber den Verlauf der Schwangerschaft, der Geburt und die Haufigkeit von Abnormitaten bei Kin‐dern von Schwangeren mit Epilepsie durchgefuhrt. 73% der 657 Frauen unter antiepileptischer Therapie bekamen lebende Kinder, 14% hatte eine Fehl‐ oder Totgeburt und bei 13% wurde ein Abort eingeleitet ImGegensatz zu diesen Ergebnissen hatten 80% von 162 Patienten ohne Antiepileptica Lebendgeburten, 4% eine Fehloder Totgeburt. Die letztere war signifikant hoher bei den Patientinnen, die Antiepileptica erhielten. In dieser Serie waren 63 von 638 Lebendgeburten (9.9%) miRbildet, 55 (1 1.5%) stammten von therapier‐ten Muttern, 3 (2,3)%) von nicht therapierten Muttern. Die Haufigkeit fetaler Fehlbildungen bei therapierten war 5mal hoher als bei nicht therapierten Muttern. Lippen‐ und/oder Gaumenspalte und MiRbildungen im kardiovaskularen Bereich wurden haufig bei Kindern therapierter Mutter gefunden. Die allgemeinen Hintergrundsfaktoren, die einen teratogenen EinfluR auf Schwangere mit Epilepsie ausuben konnten, wurden untersucht und die mogliche Toxicitat der Antiepileptica auf den Fetus analysiert. In diesen Untersuchungen sollte berucksichtigt werden, ob der Patient fokale epileptische Anfalle hat, o b e r selbst eine MiDbildung hat oder ob fruhere Schwangerschaften abnorm endeten. Die Haufigkeit der fetalen Fehlbildungen war am groRten (12.7%) bei therapiertenPatienten, die epileptische Anfalle wahrend der Schwangerschaft bekamen. Aufgrund dieser Resultate wird angenommen, daR die Kombination von mehr als 3 Medikamenten und eine tagliche Dosierung oberhalb eines Grenzwertes wahrscheinlich zu fehlgebildeten Kindern fuhren.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanson, J. W., & Smith, D. W. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80604-4 · Cited by 601
Hanson, J. W., Myrianthopoulos, N. C., Harvey, M. A. S., & Smith, D. W. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80414-3 · Cited by 434
MATERNAL EPILEPSY AND ABNORMALITIES OF THE FETUS AND NEWBORN
Speidel, B. D., & Meadow, S. R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92209-x · Cited by 415
A study of major congenital defects in Japanese infants.
Neel, J. V. (1958) · PubMed Central · Cited by 289
ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTS
Shapiro, S., Hartz, S., Siskind, V., Mitchell, A., Slone, D., Rosenberg, L., Monson, R., Heinonen, O., Idänpàan-Heikkilä, J., Häró, S., et al. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91403-3 · Cited by 263
ANTICONVULSANT DRUGS AND CONGENITAL ABNORMALITIES
Meadow, S. R. (1968) · The Lancet · doi:10.1016/s0140-6736(68)91781-9 · Cited by 263
Associations Between Oral Clefts and Drugs Taken During Pregnancy
SAXÉN, I. (1975) · International Journal of Epidemiology · doi:10.1093/ije/4.1.37 · Cited by 248
ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTS
SHAPIRO, S., SLONE, D., HARTZ, S. C., ROSENBERG, L., SISKIND, V., MONSON, R. R., MITCHELL, A. A., & HEINONEN, O. P. (1976) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197608000-00012 · Cited by 245
Diphenylhydantoin and Selected Congenital Malformations
Monson, R. R., Rosenberg, L., Hartz, S. C., Shapiro, S., Heinonen, O. P., & Slone, D. (1973) · New England Journal of Medicine · doi:10.1056/nejm197311152892001 · Cited by 240
Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study
Fedrick, J. (1973) · BMJ · doi:10.1136/bmj.2.5864.442 · Cited by 229
Cited by
Drugs in Pregnancy and Lactation
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-11-902_3 · Cited by 1,075
Comparative safety of antiepileptic drugs during pregnancy
Hernández-Díaz, S., Smith, C. R., Shen, A., Mittendorf, R., Hauser, W. A., Yerby, M., Holmes, L. B., For the North American AED Pregnancy Registry, North American AED (Antiepileptic Drug) Pregnancy Registry, Cragan, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f39 · Cited by 620
The importance of drug interactions in epilepsy therapy
Patsalos, P. N., Fröscher, W., Pisani, F., & Van Rijn, C. M. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.13001.x · Cited by 455
Pattern of Malformations in the Children of Women Treated with Carbamazepine during Pregnancy
Jones, K. L., Lacro, R. V., Johnson, K. A., & Adams, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906223202505 · Cited by 447
Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.5.592 · Cited by 434
Metadata
- Authors
- Nakane, Y., Okuma, T., Takahashi, R., Sato, Y., Wada, T., Sato, T., Fukushima, Y., Kumashiro, H., Ono, T., Takahashi, T., Aoki, Y., Kazamatsuri, H., Inami, M., Komai, S., Seino, M., Miyakoshi, M., Tanimura, T., Hazama, H., Kawahara, R., Otsuki, S., Hosokawa, K., Inanaga, K., Nakazawa, Y., & Yamamoto, K.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 1980-12
- Volume
- 21
- Issue
- 6
- Pages
- 663-680
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2148062934
- Cited by
- 301
- References
- 24
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in Japan. https://app.cochat.ai/papers/10.1111/j.1528-1157.1980.tb04320.x
- The paper
- Nakane, Y., Okuma, T., Takahashi, R., Sato, Y., Wada, T., Sato, T., Fukushima, Y., Kumashiro, H., Ono, T., Takahashi, T., Aoki, Y., Kazamatsuri, H., Inami, M., Komai, S., Seino, M., Miyakoshi, M., Tanimura, T., Hazama, H., Kawahara, R., . . . Yamamoto, K. (1980). Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in Japan. Epilepsia. https://doi.org/10.1111/j.1528-1157.1980.tb04320.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.